Skip to content

Insider · CIK 0001377832

Matthew Strobeck

director

Files at BDSX (BIODESIX INC), QDEL (QuidelOrtho Corp). First filing Nov 6, 2024, latest Nov 6, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$56k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BDSX: BIODESIX INC

BDSXOct 9, 2026 · close 26.02

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
43Moderate
BDSXbuy 5
BIODESIX INC
$56k
40,000 shares
+47%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 2, 2026BDSX
BIODESIX INC
AGrant or award
Restricted Stock Unitsderivative
+6,804$0.00$06,804Jan 6, 2026
Jan 2, 2026BDSX
BIODESIX INC
AGrant or award
Stock Options (Right to Buy)derivative
+6,354$0.00$06,354Jan 6, 2026
May 29, 2025QDEL
QuidelOrtho Corp
AGrant or award
Restricted Stock Units (Equity Grant)derivative
+6,829$0.00$06,829Jun 2, 2025
May 22, 2025QDEL
QuidelOrtho Corp
AGrant or award
Common Stock
+4,929$0.00$017,775May 27, 2025
May 22, 2025QDEL
QuidelOrtho Corp
MOption exercise
Restricted Stock Units (Equity Grant)derivative
-4,929$0.00$00May 27, 2025
May 20, 2025BDSX
BIODESIX INC
AGrant or award
Restricted Stock Unitsderivative
+80,525$0.00$080,525May 22, 2025
May 20, 2025BDSX
BIODESIX INC
AGrant or award
Stock Options (Right to Buy)derivative
+42,010$0.00$042,010May 22, 2025
Nov 5, 2024BDSX
BIODESIX INC
POpen-market purchase
Common Stockindirect: By Birchview Capital Separately Managed Account
+4,000$1.40$5,59289,673Nov 6, 2024
Nov 5, 2024BDSX
BIODESIX INC
POpen-market purchase
Common Stockindirect: By Birchview Fund LLC
+36,000$1.40$50k2,606,879Nov 6, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Matthew Strobeck: insider trades and track record | InsiderTell